StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Check Out Our Latest Stock Analysis on SenesTech
SenesTech Price Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- What is the Nikkei 225 index?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Calculate Options Profits
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Use Stock Screeners to Find Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.